Your browser doesn't support javascript.
loading
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
Rudd, Stacey E; Roselt, Peter; Cullinane, Carleen; Hicks, Rodney J; Donnelly, Paul S.
Afiliación
  • Rudd SE; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria 3010, Australia. pauld@unimelb.edu.au.
  • Roselt P; Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne 3000, Victoria, Australia.
  • Cullinane C; Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne 3000, Victoria, Australia and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. Rod.Hicks@petermac.org.
  • Hicks RJ; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. Rod.Hicks@petermac.org and Centre for Cancer Imaging, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne 3000, Victoria, Australia.
  • Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria 3010, Australia. pauld@unimelb.edu.au.
Chem Commun (Camb) ; 52(80): 11889-11892, 2016 Sep 29.
Article en En | MEDLINE | ID: mdl-27711378
Asunto(s)
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Deferoxamina / Anticuerpos Monoclonales Humanizados / Trastuzumab Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Chem Commun (Camb) Asunto de la revista: QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Australia
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Deferoxamina / Anticuerpos Monoclonales Humanizados / Trastuzumab Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Chem Commun (Camb) Asunto de la revista: QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Australia